4Laufs, G ertz, Hung. Atorvastatin upregulates type Ⅲnitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice.Stroke, 2000,31:2442.
二级参考文献38
1Farnier M, Davignon J. Current and future treatment of hyperlipidemia: the role of statins. Am J Cardiol, 1998, 82: 3J - 10J.
2Scandinavian Simvastatin Survival Study Gtoup.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival study(4S). Lancet, 1994, 344:1383 - 1389.
3Sacks FM, Pfeffer MA, Moye LA, et al. for the cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med, 1996, 335:1001 - 1009.
4The Long-Term Intervention with Pravastatin ia Ischaemic Disease(LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998, 339:1349 - 1357.
5Plehn JF, Davis BR Sacks FM, et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events(CARE)study. the CARE Investigators. Circulation,1999, 99:216 -223.
6Pedersen TR, Kjekshus J, Pyorala K, et al. Eeffect of simvastatin on ischemia signs and symptoms ia the Scandinavian Simvastatin Survival Study(4S). Am J Cardiol, 1998, 81:333 -335.
7Shepherd J, Cobbe SM, Ford I, et al. for the West Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med,1995, 333:1301 - 1307.
8Crouse JR, Byington RP, Hoen HM, et al. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med, 1997, 157:1305 -1310.
9Downs JR, Clearfield M, Weis S, et al. for the AFCAPS/Tex CAPS Research Group. Primary prevention of acute coronary events with lovastatin ka men and women with average cholesterol levels. JAMA,1998, 279:1515 - 1622.
10Blauw GJ, Lagaay AM, Smelt AH, et al. Stroke, statins, and cholesterol: a meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inbibitors. Stroke, 1997, 28:946 - 950.
